Related Experiment Video
Updated: May 14, 2026
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
1Department of Biostatistics, University of Washington, Seattle, WA 98195, USA. mjuraska@u.washington.edu
Biometrics
|February 21, 2013
Summary
This study introduces a new statistical model to assess HIV vaccine efficacy by analyzing genetic distances between HIV strains and vaccine sequences. The methods improve estimation efficiency and were applied to data from the Thai RV144 HIV vaccine trial.
Area of Science:
- Biostatistics
- Vaccinology
- Epidemiology
Background:
- Assessing HIV vaccine efficacy requires understanding how viral genetic diversity impacts protection.
- Previous methods may not fully capture the relationship between genetic distance and vaccine effectiveness.
Purpose of the Study:
- To develop a statistical framework for evaluating mark-specific vaccine efficacy in HIV prevention trials.
- To assess the relationship between vaccine efficacy and genetic distances of infecting HIV strains to vaccine sequences.
Main Methods:
- Development of a multivariate mark-specific hazard ratio model within a competing risks failure time analysis.
- Application of semiparametric maximum profile likelihood estimation for improved efficiency.
- Proposal of testing procedures for mark-specific vaccine efficacy hypotheses.
Main Results:
- The proposed model enhances estimation efficiency for vaccine efficacy related to viral genetic distance.
- The methods were successfully applied to real-world data from the RV144 HIV vaccine trial.
- Investigated asymptotic properties and finite-sample performance of inferential procedures.
Conclusions:
- The developed statistical model provides a robust approach to assess HIV vaccine efficacy in the context of viral genetic diversity.
- This framework allows for more precise evaluation of vaccine performance against different HIV strains.
- The study offers valuable insights for future HIV vaccine trial design and analysis.
Related Concept Videos
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...